151 related articles for article (PubMed ID: 27405876)
1. Interleukin 21 - its potential role in the therapy of B-cell lymphomas.
Bhatt S; Sarosiek KA; Lossos IS
Leuk Lymphoma; 2017 Jan; 58(1):17-29. PubMed ID: 27405876
[TBL] [Abstract][Full Text] [Related]
2. Direct and immune-mediated cytotoxicity of interleukin-21 contributes to antitumor effects in mantle cell lymphoma.
Bhatt S; Matthews J; Parvin S; Sarosiek KA; Zhao D; Jiang X; Isik E; Letai A; Lossos IS
Blood; 2015 Sep; 126(13):1555-64. PubMed ID: 26194763
[TBL] [Abstract][Full Text] [Related]
3. Anti-CD20-interleukin-21 fusokine targets malignant B cells via direct apoptosis and NK-cell-dependent cytotoxicity.
Bhatt S; Parvin S; Zhang Y; Cho HM; Kunkalla K; Vega F; Timmerman JM; Shin SU; Rosenblatt JD; Lossos IS
Blood; 2017 Apr; 129(16):2246-2256. PubMed ID: 28137826
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-21: biology and application to cancer therapy.
Andorsky DJ; Timmerman JM
Expert Opin Biol Ther; 2008 Sep; 8(9):1295-307. PubMed ID: 18694350
[TBL] [Abstract][Full Text] [Related]
5. Novel IL-21 signaling pathway up-regulates c-Myc and induces apoptosis of diffuse large B-cell lymphomas.
Sarosiek KA; Malumbres R; Nechushtan H; Gentles AJ; Avisar E; Lossos IS
Blood; 2010 Jan; 115(3):570-80. PubMed ID: 19965678
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneous expression and function of IL-21R and susceptibility to IL-21-mediated apoptosis in follicular lymphoma cells.
de Totero D; Capaia M; Fabbi M; Croce M; Meazza R; Cutrona G; Zupo S; Loiacono F; Truini M; Ferrarini M; Ferrini S
Exp Hematol; 2010 May; 38(5):373-83. PubMed ID: 20193734
[TBL] [Abstract][Full Text] [Related]
7. High IL-21 receptor expression and apoptosis induction by IL-21 in follicular lymphoma.
Akamatsu N; Yamada Y; Hasegawa H; Makabe K; Asano R; Kumagai I; Murata K; Imaizumi Y; Tsukasaki K; Tsuruda K; Sugahara K; Atogami S; Yanagihara K; Kamihira S
Cancer Lett; 2007 Oct; 256(2):196-206. PubMed ID: 17624663
[TBL] [Abstract][Full Text] [Related]
8. Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity.
Søndergaard H; Coquet JM; Uldrich AP; McLaughlin N; Godfrey DI; Sivakumar PV; Skak K; Smyth MJ
J Immunol; 2009 Dec; 183(11):7326-36. PubMed ID: 19915059
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-21 signaling: functions in cancer and autoimmunity.
Davis ID; Skak K; Smyth MJ; Kristjansen PE; Miller DM; Sivakumar PV
Clin Cancer Res; 2007 Dec; 13(23):6926-32. PubMed ID: 18056166
[TBL] [Abstract][Full Text] [Related]
10. The role of IL-21 in hematological malignancies.
Ma J; Ma D; Ji C
Cytokine; 2011 Nov; 56(2):133-9. PubMed ID: 21824785
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-21: an interleukin-2 dependent player in rejection processes.
Baan CC; Balk AH; Dijke IE; Korevaar SS; Peeters AM; de Kuiper RP; Klepper M; Zondervan PE; Maat LA; Weimar W
Transplantation; 2007 Jun; 83(11):1485-92. PubMed ID: 17565322
[TBL] [Abstract][Full Text] [Related]
12. The IL-15-Based ALT-803 Complex Enhances FcγRIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas.
Rosario M; Liu B; Kong L; Collins LI; Schneider SE; Chen X; Han K; Jeng EK; Rhode PR; Leong JW; Schappe T; Jewell BA; Keppel CR; Shah K; Hess B; Romee R; Piwnica-Worms DR; Cashen AF; Bartlett NL; Wong HC; Fehniger TA
Clin Cancer Res; 2016 Feb; 22(3):596-608. PubMed ID: 26423796
[TBL] [Abstract][Full Text] [Related]
13. Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease.
Liu Z; Yang L; Cui Y; Wang X; Guo C; Huang Z; Kan Q; Liu Z; Liu Y
Inflamm Bowel Dis; 2009 Aug; 15(8):1133-44. PubMed ID: 19322899
[TBL] [Abstract][Full Text] [Related]
14. IL-21: roles in immunopathology and cancer therapy.
Søndergaard H; Skak K
Tissue Antigens; 2009 Dec; 74(6):467-79. PubMed ID: 19845910
[TBL] [Abstract][Full Text] [Related]
15. IL-21: a pleiotropic cytokine with potential applications in oncology.
Croce M; Rigo V; Ferrini S
J Immunol Res; 2015; 2015():696578. PubMed ID: 25961061
[TBL] [Abstract][Full Text] [Related]
16. [Effects of humanized interleukin 21 on anti-leukemic activity of cytokine induced killer cells and the mechanism].
Zhao N; Zhao MF; Rajbhandary S; Lu WY; Zhu HB; Xiao X; Deng Q; Li YM
Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):823-8. PubMed ID: 23384903
[TBL] [Abstract][Full Text] [Related]
17. Treatment of IL-21R-Fc control autoimmune arthritis via suppression of STAT3 signal pathway mediated regulation of the Th17/Treg balance and plasma B cells.
Ryu JG; Lee J; Kim EK; Seo HB; Park JS; Lee SY; Moon YM; Yoo SH; Park YW; Park SH; Cho ML; Kim HY
Immunol Lett; 2015 Feb; 163(2):143-50. PubMed ID: 25447400
[TBL] [Abstract][Full Text] [Related]
18. Dissociation of its opposing immunologic effects is critical for the optimization of antitumor CD8+ T-cell responses induced by interleukin 21.
Ansén S; Butler MO; Berezovskaya A; Murray AP; Stevenson K; Nadler LM; Hirano N
Clin Cancer Res; 2008 Oct; 14(19):6125-36. PubMed ID: 18829491
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-21 up-regulates interleukin-21R expression and interferon gamma production by CD8+ cells in SHIV-infected macaques.
Zhao CC; Gao XQ; Xue J; Cong Z; Zhang WL; Chen T; Wu FX; Xiong J; Ju B; Su A; Wei Q; Qin C
Exp Biol Med (Maywood); 2013 Apr; 238(4):400-9. PubMed ID: 23760006
[TBL] [Abstract][Full Text] [Related]
20. IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells.
Burgess SJ; Marusina AI; Pathmanathan I; Borrego F; Coligan JE
J Immunol; 2006 Feb; 176(3):1490-7. PubMed ID: 16424177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
